CWBR News and Press, CohBar Inc. From 07/19/23

NEW YORK, NY / ACCESSWIRE / July 19, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Chinook Therapeutics, Inc. (NASDAQ...

IFx-Hu2.0 demonstrated to have a promising safety profile at all 3 dose schedules tested 5 of 7 (71%) of patients achieved durable systemic anti-tumor responses following IFx-Hu2.0 therapy and rechallenge with an immune checkpoint inhibitor (ICI) in patients who exhibited primary resist...

TAMPA, Fla. and MENLO PARK, Calif., May 30, 2023 (GLOBE NEWSWIRE) -- Morphogenesis, Inc. (“Morphogenesis”), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to c...

NEW YORK, NY / ACCESSWIRE / May 25, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Prometheus Biosciences, Inc. (NASDAQ:RXDX...

2023-05-24 12:53:19 ET Gainers: Minority Equality Opportunities Acquisition ( MEOA ) +176% . Enveric Biosciences ( ENVB ) +82% . QuantaSing Group ( QSG ) +61% . EpicQuest Education Group ( EEIQ ) +51% . GigaCloud Technology ( GCT ) ...

2023-05-24 10:07:34 ET Gainers: Enveric Biosciences ( ENVB ) +100% . Zura Bio ( ZURA ) +37% . Kamada ( KMDA ) +19% . Organogenesis ( ORGO ) +16% . OptimizeRx ( OPRX ) +14% . Losers: PTC Therapeutics ( PTCT ) -24% ....

2023-05-24 08:38:01 ET CohBar ( CWBR ) -22% . HeartCore Enterprises ( HTCR ) -21% . Navitas Semiconductor Corporation NVTS -20% commences $80M public offering . PTC Therapeutics PTCT -19% abandons preclinical gene therapy programs, cuts staff; C...

CohBar, Inc. (NASDAQ: CWBR) is one of today's top gainers. The company's shares are currently up 120.65% on the day to $3.42. CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and...

2023-05-23 10:08:04 ET Gainers: CohBar ( CWBR ) +157% . Ocean Biomedical ( OCEA ) +79% . Shuttle Pharmaceuticals ( SHPH ) +46% . Icosavax ( ICVX ) +31% . Recursion Pharmaceuticals ( RXRX ) +20% . Losers: NantHealth ( ...

2023-05-23 08:50:23 ET CohBar ( NASDAQ: CWBR ) is merging with privately held personalized cancer vaccine developer Morphogenesis and the combined company is expected to operate under the name TuHURA Biosciences Inc. Under the agreement, each holder of CohBar common stock will b...